Dr. Darren Walsh

Darren received his PhD in 2022 from DCU and the NIH, where he studied the effect of B Vitamins on mitochondrial DNA heteroplasmy in the Parle-McDermott Group and Brody Group, respectively. He received his BSc in Genetics and Cell Biology at DCU in 2017 and as such his expertise is in molecular genetics and bioinformatics. Darren then lectured at DCU as sabbatical cover for a year before joining the Duncan group in the Dublin Dental University Hospital studying regenerative medicine in pulp tissue. He has now joined the Smales group as a postdoctoral researcher and will work on a project titled ‘Enhancing Advanced Biotherapeutic Design, Manufacturing and Activity: Defining and leveraging the Biological Rules that Underpin AAV gene therapy, IVTmRNA and Protein Biotherapeutic Design and Production’.